PEAK6’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Buy
75,000
+54,800
+271% +$1.83M 0.01% 1189
2026
Q1
$608K Sell
20,200
-931,800
-98% -$30M ﹤0.01% 1895
2025
Q4
$29.7M Buy
+952,000
New +$23.5M 0.06% 279
2025
Q1
– Sell
-44,900
Closed -$990K – 3621
2024
Q4
$990K Buy
+44,900
New +$817K ﹤0.01% 1814

Other funds holding TEVA

PEAK6's TEVA Position: Q2 2026 in Review

PEAK6 opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 384 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #2544 among its holdings. This is a return to the name: PEAK6 previously reported a position in TEVA as recently as Q3 2025.

PEAK6 first reported a position in TEVA in Q2 2025 and has held it in 3 quarters since. The position peaked at $151K in Q2 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • PEAK6 held 384 shares of Teva Pharmaceutical Industries Limited worth $13K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new PEAK6 position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2544 holding.
  • PEAK6 first reported a position in Teva Pharmaceutical Industries Limited in Q2 2025 and has held it in 3 quarters since.
  • PEAK6's Teva Pharmaceutical Industries Limited position peaked at $151K in Q2 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.